BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 0 | 0 | 0 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -145.8M | -80.9M | -64.8M |
| EBITDA | -145.2M | -80.7M | -64.7M |
| Net Income | -134.0M | -74.3M | -64.7M |
| Per Share Data | |||
| EPS (diluted) | $-4.30 | $-0.94 | $-0.92 |
| Shares Outstanding (dil.) | 31M | 79M | 70M |
BridgeBio Oncology Therapeutics, Inc. Income Statement — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's income statement history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.